Author Correction: Somatic chromosomal engineering identifies BCAN-NTRK1 as a potent glioma driver and therapeutic target.
| Autor: | Cook, Peter J., Thomas, Rozario, Kannan, Ram, de Leon, Esther Sanchez, Drilon, Alexander, Rosenblum, Marc K., Scaltriti, Maurizio, Benezra, Robert, Ventura, Andrea |
|---|---|
| Zdroj: | Nature Communications; Mar2018, Vol. 9, p16187, 1p |
| Abstrakt: | This corrects the article DOI: 10.1038/ncomms15987 [ABSTRACT FROM AUTHOR] |
| Databáze: | Complementary Index |
| Externí odkaz: |
|